Nebenwirkungen · Tagrisso
TAGRISSO 40 mg film-coated tablets TAGRISSO 80 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 10
HOS-135409 · Präparat HOS-097706
Patients with a medical history of ILD, drug-induced ILD, radiation pneumonitis that required steroid treatment, or any evidence of clinically active ILD were excluded from clinical studies. Patients with clinically important abnormalities in rhythm and conduction as measured by resting electrocardiogram (ECG) (e.g. QTc interval greater than 470 msec) were excluded from these studies. Patients were evaluated for LVEF at screening and every 12 weeks thereafter.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-18T16:00:00Z · SHA-256 36d1f10f3b323cac93ed4124915e050ad98541d8f140829a41c0c4e0ad3343cb · Passage 6467382068472e311d28cde117495e31e5994a614be3aab4883dc201381e7708 · Zeichen 1773–2237 im Abschnitt